Buy Edemax 30ml Online

Edemax 30ml is a veterinary injectable formulated as a combination of dexamethasone sodium phosphate 0.06% and trichlormethiazide 1%. The product is identified by the manufacturer, Productos Veterinarios S.A. (Zoovet), as a steroidal anti-inflammatory and diuretic preparation for veterinary use. The 30 ml presentation is documented for cattle, horses, and sheep, with equine applications including edema and congestion of various origins and edema associated with allergic manifestations.

For World Equine Vet, this page provides an informative overview of Edemax 30ml, including its formulation, veterinary context, product characteristics, precautions, handling considerations, and purchasing information. Because Edemax contains a corticosteroid and a diuretic, its use should be determined by a qualified veterinary professional according to the product labeling and applicable regulations.

What Is Edemax 30ml?

Edemax 30ml is a veterinary injectable containing two active pharmaceutical ingredients: dexamethasone sodium phosphate and trichlormethiazide. According to Zoovet’s product information, the formulation combines a corticosteroid with a thiazide-type diuretic.

The product is supplied in a 30 ml presentation and is intended for veterinary applications involving conditions where inflammation, congestion, or edema may be clinically relevant. For horses, the manufacturer’s listed indications include congestion and edema of diverse origins, dependent edema, and edema associated with allergic manifestations.

Edemax is therefore different from a general-purpose supplement or routine wellness product. Its pharmacological ingredients can influence inflammatory processes and fluid balance, meaning that product selection and administration should be based on the animal’s individual clinical circumstances.

Edemax 30ml Overview

The official Zoovet product page confirms the 30 ml presentation and identifies the active formulation as dexamethasone 0.06% with trichlormethiazide 1%.

Edemax 30ml Formula

The formulation documented for Edemax consists of:

• Dexamethasone sodium phosphate — 0.06%
• Trichlormethiazide — 1%

The same composition is reported by veterinary product references describing the Zoovet formulation.

These two ingredients have different pharmacological roles. Dexamethasone is a corticosteroid, while trichlormethiazide is a thiazide-type diuretic. Combining these components gives Edemax a specific veterinary role rather than making it simply an anti-inflammatory or simply a diuretic.

Because pharmaceutical formulations and approved uses can vary between countries, buyers should confirm that the product and its labeling correspond to the jurisdiction in which it will be used.

Key Product Features

Dual-ingredient veterinary formulation

Edemax combines an anti-inflammatory corticosteroid with a diuretic ingredient. This formulation is intended for veterinary situations in which the properties of both components may be clinically relevant.

30ml injectable presentation

The product is available in a 30 ml vial presentation. Zoovet’s product information specifically lists 30 ml as an available presentation.

Equine use information

Horses are among the species listed for Edemax. The manufacturer’s equine indications include congestion and edema of diverse origins, dependent edema, and edema associated with allergic manifestations.

Veterinary pharmaceutical product

Edemax should be treated as a veterinary pharmaceutical product rather than a nutritional supplement. Professional assessment is important because corticosteroids and diuretics can have clinically significant effects.

Veterinary and Equine Context

Edema refers broadly to abnormal accumulation of fluid within tissues. In horses, swelling can have many possible causes, and the underlying cause matters when determining appropriate treatment.

For example, swelling may be associated with inflammation, injury, allergic processes, circulatory problems, infection, or other medical conditions. Consequently, the presence of visible swelling does not by itself establish that a particular medication is appropriate.

The manufacturer’s listed equine uses for Edemax include congestion and edema of diverse origin, dependent edema, and allergic manifestations associated with edema.

This distinction is important for responsible product information. Edemax should not be presented as a universal treatment for every type of swelling or fluid retention.

A veterinarian can evaluate the horse, determine the likely underlying condition, consider other medications or medical problems, and decide whether a product containing dexamethasone and trichlormethiazide is appropriate.

Understanding the Active Ingredients

Dexamethasone Sodium Phosphate

Dexamethasone is a corticosteroid with potent anti-inflammatory and immunomodulatory activity. In Edemax, it is supplied as dexamethasone sodium phosphate at the concentration documented by the manufacturer.

Corticosteroids can have broad physiological effects. Their use therefore requires more consideration than simply selecting a product according to the visible symptom.

Veterinary professionals may consider factors such as:

• The underlying diagnosis
• Severity and duration of clinical signs
• Existing infections
• Concurrent medications
• The animal’s general health
• Previous corticosteroid exposure
• Relevant regulatory requirements

Because corticosteroids can affect immune and metabolic functions, inappropriate or prolonged use can present risks.

Trichlormethiazide

Trichlormethiazide is a thiazide-type diuretic. The Edemax formulation combines this ingredient with dexamethasone sodium phosphate.

Diuretics influence the body’s handling of water and electrolytes. This is one reason professional oversight is particularly important when a diuretic-containing product is considered for an animal.

Fluid balance is closely connected to electrolyte balance, cardiovascular function, kidney function, and overall hydration status. The correct clinical approach therefore depends on the reason for fluid accumulation and the horse’s overall condition.

Edema and Fluid Accumulation

Edema is a clinical sign rather than a single disease. It can develop through different mechanisms, and the appearance or location of swelling does not necessarily reveal its underlying cause.

For horses, dependent edema can occur in areas affected by gravity and reduced movement, but swelling can also occur in association with other conditions. Allergic reactions, inflammatory processes, injury, and systemic disorders can all require different approaches.

This is why Edemax should be considered within a broader veterinary assessment rather than as an automatic solution whenever swelling is noticed.

The manufacturer’s listed equine applications provide the appropriate product context, while the veterinarian determines whether the particular animal’s condition matches that context.

Product Presentation

Edemax is documented in a 30 ml vial presentation. Veterinary product references also list a 15 ml presentation in some markets, while the Zoovet Argentina product page specifically identifies 30 ml as an available presentation.

For customers researching Edemax 30ml, it is important to check:

• The product name
• Manufacturer
• Active ingredients
• Concentrations
• Vial size
• Species listed on the label
• Country-specific regulatory information
• Expiration date
• Packaging integrity
• Storage instructions supplied with the product

These details help ensure that the product being considered matches the veterinary professional’s recommendation.

Important Safety Considerations

Edemax contains pharmacologically active ingredients and should not be treated as a routine supplement.

The presence of dexamethasone means corticosteroid-related considerations are relevant, while trichlormethiazide introduces additional considerations involving fluid and electrolyte balance.

Before use, a veterinary professional should consider the animal’s health history and the reason for treatment.

Important considerations can include:

• Existing infections
• Kidney function
• Hydration status
• Electrolyte balance
• Cardiovascular conditions
• Other medications
• Previous corticosteroid treatment
• Pregnancy or reproductive considerations where relevant
• The intended use of the animal
• Competition or medication-control requirements

Do not use a product solely because a similar symptom has previously responded to treatment.

Veterinary Supervision

Edemax is an injectable veterinary pharmaceutical. Its use should therefore be determined by a qualified veterinary professional and performed according to the current manufacturer’s labeling and applicable local requirements.

The manufacturer’s product information identifies intramuscular administration for the listed veterinary applications.

This page intentionally does not provide individualized dosing instructions. The appropriate amount, frequency, duration, and route should be determined from the current approved label and the veterinarian’s assessment of the individual animal.

This is particularly important because a horse’s weight alone is not sufficient information to establish whether treatment is appropriate.

Precautions and Contraindications

The exact precautions and contraindications applicable to Edemax should be taken from the current product labeling supplied for the relevant market.

Customers should not assume that information from another country’s packaging automatically applies to their own jurisdiction.

Before purchasing or using Edemax, consider:

1. Confirm the product identity.
   Verify that the product is Edemax and that the formulation corresponds to the intended product.
2. Check the active ingredients.
   The documented formulation contains dexamethasone sodium phosphate and trichlormethiazide.
3. Confirm the species.
   Horses are among the species listed by Zoovet.
4. Consult a veterinarian.
   The underlying cause of edema should be assessed before treatment.
5. Review concurrent medication.
   Drug interactions and overlapping effects may need to be considered.
6. Check competition regulations.
   If the horse participates in regulated competition, applicable medication-control rules should be reviewed before treatment.
7. Follow the current label.
   Do not substitute internet instructions for the manufacturer’s approved directions.

Edemax and Competition Horses

Edemax should not be selected, administered, or timed around a competition for the purpose of influencing testing outcomes or circumventing medication-control rules.

This is particularly important because products containing corticosteroids and diuretics may be subject to sport-specific restrictions. Competition organizations can have their own prohibited-substance lists, withdrawal requirements, and reporting rules.

Horse owners and trainers should independently verify the applicable rules with the relevant competition authority and their veterinarian.

The focus should remain on legitimate veterinary treatment and animal welfare rather than manipulating medication timing.

Storage and Handling

Storage requirements should be taken directly from the current Edemax packaging and manufacturer’s instructions for the applicable market.

When handling a veterinary injectable, keep the product in its original packaging where practical and protect it from inappropriate environmental conditions.

Before use, check:

• Expiration date
• Vial integrity
• Label information
• Appearance of the product
• Storage history
• Any manufacturer-specific storage requirements

Do not use a vial if the packaging appears damaged, contaminated, or otherwise compromised.

Unused veterinary medicines should be handled and disposed of according to local requirements rather than being released into household waste or waterways.

Purchasing Considerations

When purchasing Edemax 30ml, product identification is more important than simply comparing names or package sizes.

A responsible buyer should confirm:

Product identity

Ensure that the product is specifically Edemax and that the formulation corresponds to the Zoovet product being sought.

Manufacturer

The documented manufacturer is Productos Veterinarios S.A. (Zoovet).

Formulation

The documented formula contains dexamethasone sodium phosphate 0.06% and trichlormethiazide 1%.

Presentation

The requested presentation is 30 ml.

Regulatory status

Veterinary medicines can have different authorization, dispensing, and import requirements between countries. For example, Costa Rica’s official SIMEV database lists Edemax as a veterinary pharmacological product and records a 30 ml presentation.

For international customers, local veterinary-medicine regulations should therefore be checked before ordering.

Shipping and Availability

Availability of Edemax 30ml can differ by country, supplier, and applicable veterinary pharmaceutical regulations.

International customers should confirm that the product may legally be purchased, imported, possessed, and used in their destination country before placing an order.

World Equine Vet can present product information to help customers research Edemax, but customers should remain responsible for complying with applicable import and veterinary-medicine requirements.

Shipping does not override local regulations. A product being available in one country does not necessarily mean that it can legally be supplied or imported into another.

Where To Buy Edemax 30ml Online

Customers researching Edemax 30ml can use World Equine Vet to review product information and purchasing details where the product is lawfully available.

Edemax is a veterinary pharmaceutical containing dexamethasone sodium phosphate and trichlormethiazide, so buyers should confirm that the product is appropriate for their animal and that any applicable professional, prescription, import, or regulatory requirements are satisfied before purchase. The manufacturer’s product information identifies horses, cattle, and sheep among the intended species.

Before completing an order, check the product presentation, formulation, destination requirements, and current availability. Where professional authorization or veterinary oversight is required, the appropriate veterinary professional should be involved.

Frequently Asked Questions

What is Edemax 30ml?

Edemax 30ml is a veterinary injectable containing dexamethasone sodium phosphate 0.06% and trichlormethiazide 1%. It is described by Zoovet as a steroidal anti-inflammatory and diuretic preparation.

Is Edemax used in horses?

Yes. Horses are one of the species listed for Edemax. The manufacturer’s equine information includes congestion and edema of diverse origins, dependent edema, and edema associated with allergic manifestations.

What are the active ingredients in Edemax?

The documented formulation contains dexamethasone sodium phosphate 0.06% and trichlormethiazide 1%.

What size is Edemax?

The product is available in a 30 ml presentation. Some markets also document a 15 ml presentation.

Is Edemax an anti-inflammatory?

Yes. Zoovet describes Edemax as a steroidal anti-inflammatory and diuretic. Its anti-inflammatory component is dexamethasone sodium phosphate.

Is Edemax a diuretic?

Yes. Edemax contains trichlormethiazide, a thiazide-type diuretic, alongside dexamethasone sodium phosphate.

Can Edemax be used for every type of swelling in a horse?

No. Swelling can have many causes, and the appropriate treatment depends on the underlying condition. A veterinarian should evaluate the horse before treatment.

How is Edemax administered?

The manufacturer’s product information identifies intramuscular administration for its listed veterinary applications.

The actual administration should follow the current approved label and veterinary direction.

Should Edemax be used without veterinary advice?

Because Edemax contains a corticosteroid and diuretic, professional veterinary assessment is appropriate before use. It should not be selected solely on the basis of a symptom such as swelling.

Can Edemax be used in competition horses?

Competition rules vary, and medication-control regulations may apply. Owners and trainers should consult their veterinarian and the relevant competition authority rather than using medication timing to attempt to avoid detection.

Where can I find Edemax 30ml?

World Equine Vet can provide product information and purchasing options where legally available. Availability and regulatory requirements vary by destination.

Final Summary

Edemax 30ml is a veterinary pharmaceutical formulation containing dexamethasone sodium phosphate 0.06% and trichlormethiazide 1%. Zoovet lists the product for cattle, horses, and sheep, with equine applications including congestion and edema of diverse origins, dependent edema, and edema associated with allergic manifestations.

Its combination of a corticosteroid and diuretic gives the product a specific pharmacological role, which is why responsible use should be based on veterinary assessment rather than general self-treatment.

For customers researching Edemax 30ml, the most important considerations are the correct formulation, 30 ml presentation, intended species, veterinary purpose, safety considerations, applicable regulations, and current manufacturer instructions.

World Equine Vet can provide a convenient place to research Edemax 30ml and review purchasing information where lawful. Customers should always verify local veterinary-medicine requirements and seek appropriate professional guidance before using a regulated veterinary pharmaceutical.